The FDA warns that gabapentin can contribute to serious breathing problems in some people, particularly when it is combined with opioids or other central nervous system depressants. The warning is not a prediction that every combination will cause harm; it is a reason to make the full medication list and relevant health conditions visible to a clinician.
Slow, shallow, or difficult breathing; extreme sleepiness; confusion; or being unusually hard to wake can be an emergency. Call emergency services if these occur. Do not wait for a routine appointment or try to manage a suspected breathing emergency through a dose change made without medical advice.
Gabapentin questions often appear after a new prescription for pain, a hospital visit, or a change in an opioid or sleep medicine. The search phrase “gabapentin and breathing problems” may sound like an automatic interaction, but the FDA warning is more specific: serious breathing difficulties have been reported in people using gabapentin or pregabalin who have certain risk factors. Opioids and other sedating medicines can increase concern, as can older age and underlying lung or breathing problems.
Understanding that distinction helps with two common mistakes. One is to dismiss the warning because a person has taken the same medicines before. The other is to abruptly stop a prescribed medicine without talking to the clinician, which can itself be unsafe. The practical response is to know the emergency signs, identify who is taking which medicine, and have a prescriber or pharmacist review the combination for that individual.
What the FDA warning says—and what it does not
The FDA safety communication describes reports of serious breathing difficulties with gabapentinoids, including gabapentin, especially when used with opioid pain medicines or other central nervous system depressants. The agency also identifies factors that can increase the risk, including older age and conditions that reduce lung function. In response, the FDA required labeling changes and advised clinicians to consider the patient’s respiratory risk when prescribing gabapentinoids.
This is a population-level safety message. It does not tell a reader whether a particular person will develop respiratory depression, and it does not prove that every episode of sleepiness is caused by gabapentin. A combination may be prescribed when the clinician judges that the benefits outweigh the risks and can monitor it appropriately. But the decision should be deliberate, not based on a prescriber or pharmacy missing a medicine that another clinician prescribed.
Gabapentin and opioids act differently, but both can affect alertness and the central nervous system. Several medicines may add to sedation even if none is described as an opioid. Examples can include some benzodiazepines, sleep medicines, muscle relaxants, anxiety treatments, and sedating antihistamines. The actual medication names matter more than broad categories from a search result.
Who should make sure the combination is reviewed?
| Situation to mention | Why the clinician needs to know | Useful information to bring |
|---|---|---|
| Gabapentin plus an opioid pain medicine | The FDA specifically warns that respiratory depression may be more likely when these are combined. | Names, strengths, schedule, whether each is regular or as-needed, and which clinician prescribed it. |
| Another medicine that causes sedation | Effects on alertness and breathing can add together even if the medicines are for different conditions. | Prescription and nonprescription products, including sleep or allergy medicines. |
| Older age, COPD, sleep-related breathing concerns, or reduced lung function | Existing respiratory vulnerability can change the risk assessment. | Diagnosis, recent flare or hospitalization, oxygen or breathing support if used, and current symptoms. |
| Recent fall, marked confusion, or trouble staying awake | These may indicate clinically important sedation or another acute problem. | When it happened, whether it followed a medicine change, and whether breathing also changed. |
| Alcohol or other sedating substances | They may further affect alertness and coordination. | Be factual about timing and amount; the goal is to assess safety, not assign blame. |
This table is not a list of conditions that automatically prohibit gabapentin. It is a prompt for a medication review. Someone with a risk factor may still receive a prescription, but the prescriber should know about it and decide what safeguards or alternatives make sense. If more than one clinician is involved, ask which one will coordinate the full plan.
Recognizing an emergency
Get emergency help for slow, shallow, labored, or irregular breathing; blue or gray lips or fingertips; extreme sleepiness; unusual confusion; or a person who cannot be awakened normally. A severe change after medicines were taken together should be treated as urgent even if the exact cause is uncertain. Do not leave a person with these symptoms alone while waiting for routine advice.
People sometimes describe a serious problem as “just being very tired.” The distinction is whether the person can wake, respond, breathe normally, and stay alert. If they cannot, do not spend time searching for a perfect explanation. Emergency clinicians can assess breathing and medication exposure. Keep the medicine containers or a current list available if doing so does not delay the call.
Not every episode of dizziness or mild fatigue is a breathing emergency. Those symptoms can have many causes. But if sedation is unexpectedly strong, worsens quickly, or follows a new combination, contact a health professional promptly. If breathing is affected or the person is hard to wake, use emergency services rather than trying to determine at home whether the symptom is “bad enough.”
If a person is unresponsive or breathing abnormally, call your local emergency number now. Online information cannot assess oxygen level, airway safety, or the cause of the change.
A short script for a prescriber or pharmacist
Medication reviews can be uncomfortable when prescriptions come from different offices. A direct, neutral opening often works: “I take gabapentin and I also have this opioid / sleep medicine. I want to check whether this combination is appropriate and what warning signs mean I should get help.” That lets the pharmacist or prescriber begin with facts rather than assumptions.
Then ask four practical questions: Is every item on my list accounted for? Does my age or breathing history change the plan? Are there activities or additional sedating products I should avoid? If I become unusually sleepy or have breathing trouble, whom do I call and how urgently? If the medicine is prescribed only as needed, ask specifically how the instructions work when another sedative is also involved.
Include medicines obtained from urgent care, dentistry, a hospital, or another specialist. Mention nonprescription sleep aids and allergy products too. If a pharmacy list is available, compare it with what is actually in the home; lists may lag behind changes. Keep one current list in a place family or caregivers can locate in an emergency, while protecting private information appropriately.
- Write down the exact product names. Gabapentin formulations are not all identical; include the label name and strength.
- Separate regular from occasional use. “As needed” medicines still matter if taken around the same time as gabapentin.
- Mention breathing and kidney history. Do not assume another office has sent the complete record.
- Ask for a written plan. Clarify who is responsible for follow-up and whom to call after hours.
What not to do while waiting for advice
Do not independently stop gabapentin, an opioid, or another prescribed medicine in response to a general article. Stopping suddenly can cause problems, and the safest response depends on the reason for treatment and the person’s current condition. If no emergency symptoms are present, contact the prescriber or pharmacist for a patient-specific review before making a change.
At the same time, do not take extra sedating medication to “counter” discomfort or use alcohol to help sleep. Do not share someone else’s prescription or rely on an old medication list. If an emergency symptom appears, the priority is urgent professional help, not a home experiment or an online interaction checker.
For ordinary sleepiness or dizziness, the separate guide to gabapentin side effects and daily safety explains how to describe the symptom. Our guide to gabapentin uses and formulations explains why the exact product name matters. If the medicine is being stopped or a refill is interrupted, see questions about stopping gabapentin safely.
Why communication gaps happen
Modern care is fragmented. One prescriber may treat chronic pain, another may prescribe gabapentin for nerve symptoms, and a third may add a short course after surgery. Each decision can make sense in isolation while the combined list still needs review. Pharmacies can help identify some interaction risks, but they may not know about every medicine, alcohol use, lung condition, or symptom unless the patient shares it.
That is why an interaction alert should trigger a conversation, not a conclusion. A warning can help the clinician weigh alternatives, check whether the combination is necessary, and decide what follow-up is needed. It does not replace judgment about the individual. If you receive conflicting advice, ask the prescribers to coordinate directly rather than trying to reconcile different instructions alone.
Bottom line
The FDA’s gabapentin warning is especially relevant to combinations with opioids or other central nervous system depressants and to people with breathing risk factors. It is not a guarantee that harm will occur, nor a reason to change a regimen without advice. Make the complete medication list visible, disclose breathing conditions and older age, and ask for a clear safety plan. Slow or difficult breathing, extreme sleepiness, or being hard to wake requires emergency help.
Sources and further reading
- FDA: Gabapentin and pregabalin drug safety communication
- MedlinePlus: Gabapentin drug information
- DailyMed: Gabapentin prescribing information
- NHS: Common questions about gabapentin
Evidence checked October 20, 2026. This material is educational and is not a patient-specific medication recommendation.